Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pandemic's hidden toll: skin allergies surge among healthcare workers

NCT ID NCT06237010

Knowledge-focused Sponsor: Centre Hospitalier Intercommunal Creteil Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study examined how the COVID-19 pandemic impacted skin allergy visits among healthcare workers. Researchers analyzed records from 341 healthcare workers who visited skin clinics before and after the pandemic. The goal was to understand if increased use of masks, gloves, and sanitizers led to more skin problems like rashes and hives.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

341 people

The number who actually took part.

Started

Mar 2024

Finished

Feb 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients who consulted for the first time between 15th march 2017 and 15th march 2023 for an occupational dermato-allergological problem and occupying a health personnel position.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients who consulted for the first time between 15th march 2017 and 15th march 2023 for an occupational dermato-allergological problem ; * Active subjects and occupying a health personnel position defined according to the Public Health Code ; * Over 18 years old at the first consultation, with no upper limit * Having not expressed their opposition to participate in the study. Exclusion Criteria: * Patients who consulted for an other problem than occupational dermato-allergological problem ; * Patients who not consulted for the first time between 15th march 2017 and 15th march 2023. * Patients without occupational activity the day of the first consultation * Patients who opposite to participation in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acne are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acne allergic contact dermatitis allergic urticaria contact dermatitis COVID-19 irritant dermatitis occupational dermatitis rosacea skin disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dermatoses Health workers

Contacts and locations

Locations

  • Centre Hospitalier Intercommunal de Créteil

    Créteil, 94000, France

  • Hôpital Hôtel Dieu

    Paris, 75004, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.